Will Home Prices Hit All-Time Highs?
CoreLogic has just released its Home Price Index and Forecast for May 2019, and it shows that home prices rose both year over year and month over month.
All Work
Chris Lange
Tuesday’s Biggest Biotech Movers
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.
Easing of Trade Concerns Lifts Semiconductors
It’s been said that a rising tide lifts all ships, and that seems to be true in Monday’s trading session following the G-20 meeting over the weekend.
How Pfizer Is Looking to Expand Its Eczema Treatment
Pfizer shares were up slightly on Monday after the firm announced topline results from its most recent late-stage study in young children with mild to moderate atopic dermatitis, also known as eczema.
4 Homebuilder Stocks Could Surge From Higher Home Sales
Each month Wedbush publishes its Top 25 report which looks at home sales, home listings, and median sales prices as published by the local Realtors' Associations. Because homebuilder pricing power is a function of…
Pfizer’s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King
Pfizer released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy. While these results did not necessarily live up to expectations, there is a winner in this.
4 Homebuilder Stocks Could Surge From Higher Home Sales
Each month Wedbush publishes its Top 25 report which looks at home sales, home listings, and median sales prices as published by the local Realtors' Associations. Because homebuilder pricing power is a function of…
RealReal Enters the Market With a Bang
RealReal entered the market with a bang on Friday. The stock opened well above the set price of $20.
Nike Can’t Keep Pace With Q4 Earnings
Nike released its fiscal fourth quarter financial results after the markets closed on Thursday. The apparel giant said that it had $0.62 in earnings per share (EPS) and $10.2 billion in revenue, compared with…
Rite Aid Surprises Big With Earnings and Amazon Partnership
Rite Aid shares soared after it reported its most recent quarterly results and on news of a partnership with Amazon.
Adaptive Biotechnologies Enters the Market With a Bang
Adaptive Biotechnologies entered the market with a bang on Thursday, well above the high end of the expected price range.
Is There Any Way Pier 1 Can Come Back From This?
Pier 1 Imports stock sank after the specialty retailer reported its most recent quarterly results.
How Walgreens Turned Itself Around in Q3
Walgreens released better-than-expected fiscal third-quarter financial results before the markets opened on Thursday.
Thursday’s Top 4 Biotech Movers
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Why Investors Are Pulling Out Their Hair Over Aclaris Alopecia Study
Aclaris Therapeutics shares sharply dropped early on Thursday after the firm announced results from its midstage trial in alopecia areata.
What to Expect When Nike Reports on Thursday
Nike is scheduled to release its fiscal fourth-quarter financial results after the markets close on Thursday.
Should FedEx Get More Credit for Its Q4 Earnings?
FedEx shares moved little after the delivery giant released mixed fiscal fourth-quarter results.
Why General Mills Is Taking a Hit on Q4 Earnings
General Mills shares retreated after it reported mixed fiscal fourth-quarter financial results early Wednesday.
Big Biotechs Scare Off Short Sellers
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Short Sellers Seek Direction on Big Pharma
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.